Sentences with phrase «uninformative cytogenetic»

Those with uninformative cytogenetic or molecular markers with negative minimal residual disease at the end of induction were noted to experience the most benefit (nearly 2-fold benefit from receiving a fifth dose of chemotherapy) vs. those with favorable cytogenetic and molecular features who did not experience benefit from receiving a fifth dose of therapy.

However, among patients who had uninformative cytogenetic or molecular features but who were MRD < 0.1 % at the end of induction I, the disease - free survival (HR, 1.86; 95 % CI, 1.18 — 2.92; P =.008) and overall survival (HR, 1.91; 95 % CI, 1.01 — 3.61; P =.046) were almost twice as high in patients who received five treatment courses compared with four courses.